Proportion of Late Presentation to HIV/AIDS Care in Yekatit 12 Hospital Medical College, Addis Ababa. 2020GC

Fitsum Terefe Asfaw^1, , Birukti Gebreyohannes Habtezgi^2, , Tewodros Kassahun Tarekegn^2, , Akinahom Tesfaye Asressahegn³, Michael Yefrashowa Betemariam², Feven Negasi Abriha⁴, Erdachew Gallo Beyene¹, Aragaw Birhane Kassaw³, Rediet Abebe Mekonnen⁵, Rediet Habtu Lebelo⁶, Tigist Delelegn woldemicheal⁷, Helen Assefa Berhe⁸, Solomon Endale Dagnachew², Elul Simeneh Abiy⁹, Betelehem Lulseged Yimer⁹ and Michael Million Minase⁸

¹Department of Surgery Yekatite 12 Hospital Medical College, Addis Ababa, Ethiopia

²Department of Medicine, Hayat Medical College, Addis Ababa, Ethiopia

³Department of Medicine, St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

⁴Department of Medicine Jimma University Oromia Region, Ethiopia

⁵Department of Public Health, Kea Med Medical College, Addis Ababa, Ethiopia

⁶Department of Medicine, Mekelle University, College of Health Science, Mekelle. Ethiopia

⁷Department of Nursing, Rifty vally univercity Addis Ababa, Ethiopia.

⁸Department of Medicine, Addis Ababa University, Tikurs Anbessa, College of Health Sciences, Ethiopia

⁹Department of Midwifery:Gonder univercity College of Medicine and Health Sciences

Cite this paper:
Fitsum Terefe Asfaw, Birukti Gebreyohannes Habtezgi, Tewodros Kassahun Tarekegn, Akinahom Tesfaye Asressahegn, Michael Yefrashowa Betemariam, Feven Negasi Abriha, Erdachew Gallo Beyene, Aragaw Birhane Kassaw, Rediet Abebe Mekonnen, Rediet Habtu Lebelo, Tigist Delelegn woldemicheal, Helen Assefa Berhe, Solomon Endale Dagnachew, Elul Simeneh Abiy, Betelehem Lulseged Yimer and Michael Million Minase. Proportion of Late Presentation to HIV/AIDS Care in Yekatit 12 Hospital Medical College, Addis Ababa. 2020GC. American Journal of Infectious Diseases and Microbiology. 2023; 11(2):30-39. doi: 10.12691/ajidm-11-2-2

Abstract

Back Ground: Acquired immune deficiency syndrome (AIDS) is one of the public health important diseases around the globe. It continues to be a major global public health issue. Late presentation for HIV care is associated with increased morbidity and mortality, increased rate of ART drug resistance and occurrence of complications, increased healthcare expenses and possibly increased HIV transmission rates. Therefore, the success of large-scale antiretroviral therapy programs depends on early initiation of HIV/AIDs are. The purpose of the study is to assess the prevalence of late presentation to HIV/AIDS care and will be a base for further studies. Objectives: The objective of this study is to assess the proportion of late presentation to HIV/AIDS care among patient attending at ART clinic of Yekatit 12 hospital medical college. Methods: Study Area: The study was conducted at Yekatit 12 hospital medical college ART clinic, Addis Ababa Ethiopia. Study design and sampling technique: A retrospective cross sectional study design was employed. All newly enrolled HIV positive patients in the study period were involved in the study. Method of data collection and analysis: Retrospective data was collected from database and patient’s card, from September, 2018 to September, 2020.using checklists which is adapted from different literatures, ART log books and previous similar study and was organized according to study objectives. Descriptive analysis was done using SPSS software and data were presented with tables and charts. Result: From a total of 229 study groups majority were females 64% with dominant age group of 25-44 yrs. 44% were married and 33.6% were attended elementary school. The overall late presenters to HIV/AIDS care was 49.7% with CD4 cell count < 200cells/mm3 40.6% and WHO clinical stage 3 and 4 30.1%. The average CD4 cell count was 275 cells/mm3. The median time to present for HIV care after initial HIV diagnosis was 4 months. The most common opportunistic infection was TB infection (pulmonary and extrapulmonary TB). Conclusion: Nearly half of the patients were late presenters categorized by either by CD4 count or WHO clinical staging. One third of them were presented with sign symptoms of advanced HIV infection.

Keywords:
late presentation HIV/AIDS care

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	World Health Organization map production: Health statics and Information System (HIS). WHO 2014.
[2]	European Centre for Disease Prevention and Control / WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2012. Stockholm: European Centre for Disease Prevention and Control; 2013.
[3]	National Guidelines for Comprehensive HIV Prevention, care and Treatment Federal Ministry of Health June, 2014.
[4]	WHO Guidline HIV/AIDS; Strategy for the WHO African region world health organization Regional Office for Africa Brazzaville, 2013.
[5]	PA Agaba, ST Meloni, HM Sule, OO Agbaji, PN Ekeh, GC Job, N Nyango, PO Ugoagwu, GE Imade, JA Idoko, and PJ Kanki. Patients who present late to HIV care and associated risk factors in Nigeria. HIV Medicine (2014).
[6]	DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents – a Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: .
[7]	Hailay A Gesesew, Fessehaye A Tesfamichael, Birtukan T Adamu. Factors Affecting Late Presentation for HIV/AIDS Care in Southwest Ethiopia: A Case Control Study. Public Health Research 2013, 3(4): 98-107.
[8]	Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F: Prog-nosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002, 360(9327): 119–129.
[9]	Centers for Disease Control and Prevention. Late versus early testing o f HIV: 16 Sites, United States, 2000–2003. MMWR Morb Mortal Wkly Rep. 2003; 52: 581–586.
[10]	Pharris A, Spiteri G, Noori T, Amato-Gauci AJ. Ten years after Dublin: principal trends in HIV surveillance in the EU/EEA, 2004 to 2013. Euro Surveill. 2014; 19(47): pii=20968.
[11]	A Antinori, T Coenen, D Costagiola, N Dedes, M Ellefson, J Gatell, E Girardi, M Johnson, 12 O Kirk, J Lundgren, A Mocroft, A d’Arminio Monforte, A Phillips, D Raben, J K Rockstroh, C Sabin, A So¨nnerborg and F de Wolf for the European Late Presenter Consensus working group. Late presentation of HIV infection: a consensus definition. British HIV Association (2010).
[12]	Vegas et al Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on Mortality, J Current HIV Research, 2009, 7, 224-230.
[13]	Girardi et al. Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy. J Acquir Immune Defic Syndr. Volume 36, Number 4, August 1 2004 Delayed.
[14]	Maeva A et al. Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: A case-case comparison AIDS Research and Therapy 2008, 5: 6 pp 12.
[15]	Patricia Garcia. Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009: AIDS Research and Therapy 2011, 8: 22.
[16]	Kamalika Mojumdar, Madhu Vajpayee, Neeraj K Chauhan and Sanjay Mendiratta. Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. Mojumdar et al. BMC Public Health 2010, 10:416.
[17]	Abrha A, Abdo Z., Assefa H. Late presentation to HIV care and its associated factors in Shashamanne Hospital, Southeastern Ethiopia: A Retrospective Study. The Journal of Infectious Diseases. Photon 113 (2014) 232-238.